Common variants at 19p13 are associated with susceptibility to ovarian cancer
the Australian Ovarian Cancer Study Group(University of Cambridge), Kelly L. Bolton(University of Cambridge), the Australian Cancer Study (Ovarian Cancer)(University of Cambridge), Jonathan P. Tyrer(University of Cambridge), Honglin Song(University of Cambridge), Susan J. Ramus(University College London), Maria Notaridou(University College London), Chris Jones(University College London), Tanya Sher(University College London), Aleksandra Gentry‐Maharaj(Moffitt Cancer Center), Eva Wozniak(Yale University), Ya-Yu Tsai(Moffitt Cancer Center), Joanne B. Weidhaas(University of Southern California), Daniel Y. Paik(University of Southern California), David J. Van Den Berg(University of Southern California), Daniel O. Stram(University of Southern California), Celeste Leigh Pearce(University of Southern California), Anna H. Wu(University of Southern California), Wendy R. Brewster(University of California, Irvine), Hoda Anton‐Culver(University of California, Irvine), Argyrios Ziogas(Memorial Sloan Kettering Cancer Center), Steven A. Narod(Institute of Cancer Research), Douglas A. Levine(Memorial Sloan Kettering Cancer Center), Stanley B. Kaye(Institute of Cancer Research), Robert Brown(Imperial College London), Jim Paul(Cancer Research UK Clinical Trials Unit), James M. Flanagan(Imperial College London), Weiva Sieh(Stanford University), Valerie McGuire(Peter MacCallum Cancer Centre), Alice S. Whittemore(Royal Marsden Hospital), Ian Campbell(Peter MacCallum Cancer Centre), Martin Gore(National Institutes of Health), Jolanta Lissowska(The Maria Sklodowska-Curie National Research Institute of Oncology), Hanna Yang(National Institutes of Health), Krzysztof Mędrek(International Hereditary Cancer Center), Jacek Gronwald(International Hereditary Cancer Center), Jan Lubiński(BC Cancer Agency), Anna Jakubowska(University of New Mexico), Nhu D. Le(Alberta Health Services), Linda S. Cook(Alberta Health Services), Linda E. Kelemen(Alberta Health Services), Angela Brooks‐Wilson(BC Cancer Agency), Leon F.A.G. Massuger(Radboud University Nijmegen), Lambertus A. Kiemeney(Radboud University Nijmegen), Katja K.H. Aben(Institute of Cancer Research), Anne M. van Altena(Centre for Human Genetics), Richard S. Houlston(Institute of Cancer Research), Ian Tomlinson(Centre for Human Genetics), Rachel T. Palmieri(Duke Medical Center), Patricia G. Moorman(Duke University), Joellen M. Schildkraut(Moffitt Cancer Center), Edwin S. Iversen(Mayo Clinic), Catherine Phelan(Mayo Clinic), Robert A. Vierkant(Mayo Clinic), Julie M. Cunningham(Mayo Clinic), Ellen L. Goode(Mayo Clinic), Brooke L. Fridley(Mayo Clinic), Susan Kruger-Kjaer(Danish Cancer Society), Jan Blaeker(Aarhus University Hospital), Estrid Høgdall(Cedars-Sinai Medical Center), Claus Høgdall(Cedars-Sinai Medical Center), Jenny Gross(Cedars-Sinai Medical Center), Beth Y. Karlan(Cedars-Sinai Medical Center), Roberta B. Ness(Roswell Park Comprehensive Cancer Center), Robert P. Edwards(Roswell Park Comprehensive Cancer Center), Kunle Odunsi(Roswell Park Comprehensive Cancer Center), Kirsten B Moyisch(Roswell Park Comprehensive Cancer Center), Julie Baker(Brown University), Francesmary Modugno(University of Pittsburgh), Tuomas Heikkinen(Helsinki University Hospital), Ralf Butzow(Helsinki University Hospital), Heli Nevanlinna(Helsinki University Hospital), Arto Leminen(Helsinki University Hospital), Natalia Bogdanova(Medizinische Hochschule Hannover), Natalia Antonenkova(Medizinische Hochschule Hannover), Thilo Doerk(Medizinische Hochschule Hannover), Peter Hillemanns(Medizinische Hochschule Hannover), Matthias Dürst(University of Hawaiʻi at Mānoa), Ingo B. Runnebaum(University of Hawaiʻi at Mānoa), Pamela J. Thompson(University of Hawaiʻi at Mānoa), Michael E. Carney(University of Hawaiʻi at Mānoa), Marc T. Goodman(University of Hawaiʻi at Mānoa), Galina Lurie(University of Hawaiʻi at Mānoa), Shan Wang‐Gohrke(German Cancer Research Center), Rebecca Hein(German Cancer Research Center), Jenny Chang‐Claude(German Cancer Research Center), Mary Anne Rossing(Fred Hutch Cancer Center), Kara L. Cushing‐Haugen(Fred Hutch Cancer Center), Jennifer A. Doherty(deCODE Genetics (Iceland)), Chu Chen(deCODE Genetics (Iceland)), Þórunn Rafnar(deCODE Genetics (Iceland)), Søren Besenbacher(deCODE Genetics (Iceland)), Patrick Sulem(deCODE Genetics (Iceland)), Kari Stefansson(Brigham and Women's Hospital), Michael J. Birrer(National Institutes of Health), Kathryn L. Terry(Brigham and Women's Hospital), Dena Hernández(National Institutes of Health), Daniel W. Cramer(Brigham and Women's Hospital), Ignace Vergote(KU Leuven), Frédéric Amant, Diether Lambrechts(University of California, Los Angeles), Evelyn Despierre(The Maria Sklodowska-Curie National Research Institute of Oncology), Peter A. Fasching(University of California, Los Angeles), Matthias W Beckmann(Friedrich-Alexander-Universität Erlangen-Nürnberg), Falk C. Thiel(QIMR Berghofer Medical Research Institute), Arif B. Ekici(Friedrich-Alexander-Universität Erlangen-Nürnberg), Xiaoqing Chen(QIMR Berghofer Medical Research Institute), Sharon E. Johnatty(QIMR Berghofer Medical Research Institute), Penelope M. Webb(National Institutes of Health), Jonathan Beesley(National Institutes of Health), Stephen J. Chanock(National Institutes of Health), Montserrat García‐Closas(National Institutes of Health), Tom Sellers(Moffitt Cancer Center), Douglas F. Easton(QIMR Berghofer Medical Research Institute), Andrew Berchuck(University of Cambridge), Georgia Chenevix‐Trench(QIMR Berghofer Medical Research Institute), Paul D.P. Pharoah(University of Cambridge), Simon A. Gayther(University College London)
Cited by 257Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis